Diabetes treatment is constantly evolving, with new therapeutic options appearing to improve patient outcomes. Recent studies have focused on GLP-1 and GIP receptor agonists, a class of drugs that mimic the actions of https://theofibi504554.actoblog.com/39817768/novel-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment